The B12 is causing the color
The study also found that non-invasive blood tests and imaging measures reflected treatment-related improvements more clearly than liver biopsies
SPEARS: It is not the doctor prescribing the exact same thing for every single patient
The FDA said it will give compounding pharmacies time to wind down "to avoid unnecessary disruption to patient treatment." The FDA said compounders have until April or May, depending on their regulatory status, to stop compounding, distributing or dispensing semaglutide injection products
Our clinic uses FibroScan technology to monitor these improvements, allowing us to track liver health changes over time
Results vary by medication, dose, treatment duration, health history, and consistency with the treatment plan